Adelaide Research & Scholarship
Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/52546
| Citations | ||
| Scopus | Web of Science® | Altmetric |
|---|---|---|
|
?
|
?
|
|
| Type: | Journal article |
| Title: | Patient-reported rating of gastrointestinal adverse effects during treatment of type 2 diabetes with the once-daily human GLP-1 analogue, liraglutide |
| Author: | Horowitz, M. Visboll, T. Zdravkovic, M. Hammer, M. Madsbad, S. |
| Citation: | Diabetes, Obesity and Metabolism: a journal of pharmacology and therapeutics, 2008; 10(7):593-596 |
| Publisher: | Blackwell Publishing Ltd |
| Issue Date: | 2008 |
| ISSN: | 1462-8902 1463-1326 |
| Statement of Responsibility: | M. Horowitz, T. Vilsbøll, M. Zdravkovic, M. Hammer and S. Madsbad |
| Keywords: | Humans Gastrointestinal Diseases Diabetes Mellitus, Type 2 Dose-Response Relationship, Drug Middle Aged Female Male Glucagon-Like Peptide 1 Incretins Liraglutide |
| Rights: | Journal Compilation © 2008 Blackwell Publishing Ltd |
| DOI: | 10.1111/j.1463-1326.2008.00861.x |
| Published version: | http://dx.doi.org/10.1111/j.1463-1326.2008.00861.x |
| Appears in Collections: | Aurora harvest Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.